A new treatment for multiple sclerosis (MS) that improves mobility for some patients earned FDA approval in January 2010. Neurologists at the University of Rochester Medical Center have studied the medication dalfampridine (marketed as Ampyra) for as an MS treatment more than 10 years.
dr. goodman - tell the truth. What is it really - fda approved a bird poisen. Dr. Goodman, if these drugs worked - why are people so crippled. CCSVI - venous disease is the problem.
MrLeooreo 1 year ago